Tuesday, November 15, 2022 7:31:36 PM
I'd like to guess Axim manufacturers a kit for $6-$8 each, sells each kit to Versea for $15 (the 6 month traunch was 10,000 kits), and Versea sells to the doctors office for a bit over $17, the cost of which is fully reimbursable by the insurance company. The doctor's charge to do the test is included in the doctor's visit cost - one that would normally have taken more of the doctors time and effort had he NOT been using the Axim test kit platform.
In other words, the doctor could now see many more patients in a single day, get results immediately, and still charge the same consultation fee but just have many more of them in the same amount of time.
I'm just guessing at a scenario, but once Versea gets a doctor "hooked" on the platform, simply selling tests at a profit of $2.50 per test kit to REPEAT customers isn't a bad profit.
Just guessing, but it does sound plausible.... .
My posts are merely my unprofessional opinion and should NEVER be seen as or used as investment advice,
Recent AXIM News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/21/2023 03:07:21 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/31/2023 08:10:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 05:35:50 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:11:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM